Youqian Chen

Youqian Chen

Auto-generated profile, based on publicly available information

Youqian Chen

College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan, 430074, PR China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2025 in ACS Nano
Verified
Journal Article
Closed access
RLRui Li
Rui Li
YZYuanzhuo Zhou
Yuanzhuo Zhou
YCYouqian Chen
Youqian Chen
LZLi Zhou
Li Zhou
YYYihui Yang
Yihui Yang
YLYanan Li
Yanan Li

28 January 2025 in Nano Letters
Verified
Journal Article
Closed access
YCYouqian Chen
Youqian Chen
YYYihui Yang
Yihui Yang
HZHanlin Zhou
Hanlin Zhou
WYWenshuai Yao
Wenshuai Yao
SZShaoqi Zeng
Shaoqi Zeng
LHLiping Huang
Liping Huang

23 October 2024 in Advanced Science
Verified
Journal Article
Open access
YCYouqian Chen
Youqian Chen
HFHongli Fan
Hongli Fan
RLRui Li
Rui Li
HZHuazhi Zhang
Huazhi Zhang
RZRui Zhou
Rui Zhou
LHLiping Huang
Liping Huang
Accurate affinity assessments play an important role in drug discovery, screening, and efficacy evaluation. Label‐free affinity biosensors are recognized as a dependable and standard technology for addressing this challenge. This study constructs a free electron density gradient‐enhanced meta‐surface plasmon resonance (FED‐MSPR) biosensor through a finite‐difference time‐domain simulation model, the biosensor demonstrates superior detection performance in accurately determining affinity and kinetic rate constants. By controlling the dielectric properties of the metal on the surface of the nanocup arrays, the plasmon resonance effects are easily tuned without changing the nanostructure design. Compared with the single‐layer gold chip, the triple‐layer FED‐MSPR chip demonstrated a four‐fold improvement in resolution at the optimal resonance peak. Additionally, the sensitivity and figure of merit (FOM) of the multi‐layer chip increased by 3.5 and 7.99 times, respectively. Following modification with high‐ and low‐staggered carboxylation, the noise‐signal ratio and baseline stability of the real‐time kinetic curves based on these chips are significantly enhanced. The developed carboxylation FED‐MSPR platform is successfully used to perform affinity assays for Adalimumab and TNF‐α protein, resulting in favorable dynamic curves. These findings validate the proposed FED‐MSPR biosensor platform as cost‐effective, rapid, sensitive, and label‐free, facilitating real‐time quality control in drug development.

13 August 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YCYouqian Chen
Youqian Chen
WYWenshuai Yao
Wenshuai Yao
RLRui Li
Rui Li
YYYihui Yang
Yihui Yang
HFHongli Fan
Hongli Fan
LHLiping Huang
Liping Huang

1 July 2025 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YCYouqian Chen
Youqian Chen
RZRui Zhou
Rui Zhou
YSYue Shu
Yue Shu
HZHanlin Zhou
Hanlin Zhou
WZWeiyi Zheng
Weiyi Zheng
LHLiping Huang
Liping Huang

28 January 2026 in Advanced Science
Verified
Journal Article
Open access
YCYouqian Chen
Youqian Chen
WLWen Li
Wen Li
JFJiaying Feng
Jiaying Feng
YSYue Shu
Yue Shu
YYYihui Yang
Yihui Yang
YLYanan Li
Yanan Li
Assessing intestinal barrier function in organ‐ and cell‐on‐a‐chip models is crucial for studying intestinal diseases and advancing drug development. However, current technologies lack methods for continuous, non‐destructive monitoring of intestinal barrier dynamics. In this study, we developed a real‐time, label‐free, high‐throughput cell‐on‐a‐chip system based on a metasurface plasmon resonance colorimetric sensor (MetaSPRCS) to evaluate intestinal barrier function. Integrating MetaSPRCS with transmission microscopy enabled real‐time visualization of cell adhesion, proliferation, and intestinal barrier layer formation, disruption, and repair. The MetaSPRCS platform non‐destructively detects subtle epithelial cell damage caused by low ethanol concentrations, with a two‐fold higher sensitivity than that of CCK‐8 assays. In an alcohol‐induced intestinal barrier injury model, MetaSPRCS validated a reliable evaluation of Dihydroquercetin (DHQ), consistent with endpoint methods. Animal experiments confirmed its ability to predict in vitro‐to‐in vivo dose conversion of DHQ, offering promising guidance for the administration of novel cell‐repairing food ingredients. This study provides a high‐throughput, visual, non‐destructive tool for assessing intestinal homeostasis, establishing a preliminary dose conversion relationship between in vitro evaluation experiments and in vivo animal administration.